u-The long-term clinical outcome is evaluated for 268 patients after chymopapain chemonucleolysis for radicular complaints referrable to documented intervertebral disc disease. The follow-up period for 92% of these patients was 10 years. No complications due to chymopapain toxicity were observed; 80.1% of patients were relieved of their presenting radicular leg pain and 75.1% were employed at a capacity equal to or more strenuous than before injection. Chemonucleolysis was demonstrated to be a safe and effective treatment modality, with long-term results that compare favorably with those of similarly selected patients undergoing open surgical procedures. In the patients whose chymopapain therapy failed, the outcome of subsequent open surgical procedures was not necessarily compromised by prior chemonucleolysis. A higher rate of failure and subsequent surgical intervention was seen in those patients with injections performed soon after an unsuccessful open procedure on the same side and at the same interspace, those with workmen's compensation or litigation pending, those with a history of work-related injury, those whose employment involved heavy manual labor or extensive driving, and those whose preinjection spine x-ray films indicated retrograde spondylolisthesis.
N
'UMEROUS forms of conservative and surgical therapy have been advocated for radicular complaints referrable to intervertebral disc disease since the pathogenesis of and surgical approach to this clinical entity were first described by Mixter and colleagues. 1' 8 The critical appraisal of chymopapain chemonucleolysis as a surgical alternative to laminectomy and discectomy demands the long-term followup analysis of large numbers of patients in order to better assess the safety and efficacy of this therapeutic modality. 3-5'7'9-13'15-17 This study seeks to contribute to this analysis.
Clinical Material and Methods

Patient Selection
Between the years 1972 and 1975, 268 patients underwent chymopapain chemonucleolysis at the Mayo Clinic. All had myelographically demonstrated intervertebral disc disease which presented clinically with unequivocal radicular signs and symptoms, and was refractory to conservative therapy. Patients with profound or progressive single-root motor deficits or with signs of cauda equina deficit were excluded from consideration as candidates for chemonucleolysis.
Each patient was evaluated preoperatively by a medical neurologist after a general medical examination, appropriate blood studies, and x-ray films of the chest and lumbar spinal column. If all conservative measures failed to afford relief and the patient was deemed an appropriate surgical candidate, Pantopaque myelography of the entire spinal column was carried out. This was considered an essential step in the preoperative evaluation, since approximately 5% of a prior series of 1250 patients at the Mayo Clinic suffering from typical discogenic symptoms proved to have intraspinal tumors. 6 Patients with complete myelographic blocks to the flow of contrast dye were excluded from consideration as candidates for chemonucleolysis. Also excluded were those patients with lumbosacral disc protrusions whose radiographs demonstrated lumbosacral interspaces with high-riding iliac crests or large transverse processes bordering on sacralization --a combination which would make the lateral extradural approach for needle insertion into the lumbosacral disc space impossibleJ ~ A period of at least 48 hours was allowed to elapse after myelography; the occasional postmyelographic headache required delaying the procedure further.
The mean age at injection was 39.4 years; 178 patients were male and 90 were female (Table 1) . Eightyfive were engaged in sedentary employment, 94 in light manual labor, 69 in heavy manual labor, and 20 in occupations involving extensive driving of motor vehicles. Sixty-two of this group had compensation or litigation pending at the time of initial evaluation, and 12 had undergone previous lumbar spine surgery. Two hundred fifty-one suffered with back pain, 248 had unilateral leg pain, 10 had asymmetrical bilateral leg pain, and 10 had only unilateral buttock or hip pain.
The mean duration of chronic symptoms referrable to their degenerative disc disease was 75.1 months. The mean duration of the most recent symptoms, or acute exacerbation prompting medical treatment, was 6.3 months. On physical examination, reflex changes were present in 112 patients, mild sensory deficit in 62, and mild motor deficit in 83.
Radiographic Studies
Plain lumbar spine radiographs obtained prior to chemonucleolysis demonstrated a narrowing of the specific interspace in 157 cases (58.6%), spondylotic changes in 148 instances (55.2%), an incidental spina bifida in 10 patients, spondylolysis distant from the relevant interspace in six cases, and spondylolisthesis at the involved level in four patients. The Pantopaque myelograms of all 268 patients were abnormal because this was a criterion for inclusion. Discography was performed in 223 patients at the time of chemonucleolysis. The myelogram and discogram agreed totally in R. J. Maciunas and B. M. Onofrio 146 patients and disagreed in 77. When an additional abnormal disc was identified on discography at a level adjacent to the myelographically demonstrated focal disc protrusion, then both levels were injected with chymopapain. This occurred predominantly in the earlier cases of the series, when discography was performed at L-4 and L-5 if the myelographic defect was at one of these levels. Owing to the ubiquity of abnormal discograms in this setting, discography was performed more selectively toward the end of the series in order to confirm myelographically demonstrated pathology, to define further disc spaces poorly visualized owing to short or posteriorly lying thecal sacs (a role now largely assumed by computerized tomography (CT) metrizamide scanning)y or to verify nuclear penetration when the intradiscal needle placement was slightly eccentric. J o
Method of Chemonucleolysis
After endotracheal induction of general anesthesia, the patient was placed in the left lateral decubitus position upon a chemonucleolysis operating table. After preparation and draping, a 6-in. No. 18 needle was inserted into the back 8 to 10 cm from the midline and directed into the centrum of the clinically relevant nucleus pulposus with the aid of anteroposterior and lateral fluoroscopy. Discography was accomplished by injection of 1 ml of 60% of Renografin once the needle was demonstrated to be in the optimum position. If the needle could not be introduced into the interspace by the lateral approach without violating the dura, the entire procedure was terminated. Reverting to the midline transdural approach for needle placement into the disc was considered an unwarranted risk. To effect chemonucleolysis, 1 to 2 ml of chymopapain, 2000 U/ml, was injected into the interspace. The needle was left in place for 5 minutes, then removed.
One disc was injected in 134 patients, two discs in 124, and three discs in 10. Four patients were injected at the L-3 interspace, 66 at L-4, 64 at L-5, nine patients at L-3 plus L-4, 115 patients at L-4 plus L-5, and 10 patients at L-3, L-4, and L-5.
Postoperative paraspinal muscle spasms of several days' duration were noted in 106 patients (40%). These were treated with Hubbard tank therapy and muscle relaxants as indicated. The occurrence or absence of muscle spasms did not correlate with ultimate clinical outcome. There were no instances of allergic reactions, anaphylaxis, subarachnoid hemorrhage, myelopathy, or disc space infection in this series. Patients were observed in the hospital for an average of 3 days after chemonucleolysis, and 6 weeks were allotted for recuperation prior to resumption of employment.
Results of Treatment
Clinical follow-up data were obtained for each patient with regard to employment status, leg pain, back pain, motor deficits, sensory disturbances, further radio- graphic studies (including spinal column x-ray films, myelograms, CT scans, or discograms), and any further related medical or surgical intervention. Data were compiled for follow-up times of 1 week, 3 months, 1 year, 5 years, and 10 years after chemonucleolysis.
Results were obtained by a multifactorial questionnaire in those instances where up-to-date information was not available from Mayo Clinic chart review. When questions arose as to interpretation of the questionnaire or when questionnaires were not answered, telephone communication was used. Outside medical records and relevant radiographic examinations were reviewed by the authors, and a special effort was made to discuss patients' medical histories personally with their local physicians. When several sources of follow-up information regarding clinical status demonstrated differences, the questionnaire categories were invariably scored from the "worst-case" response obtained for that patient at that time. Although this might tend to negatively skew the outcomes reported by consistently applying this rigid system for scoring responses, an overly optimistic reporting of clinical outcome was avoided. When pain was the substrate being examined, the pa- tient was found to be the best source for 10-year data. Nine patients died within 10 years after chemonucleolysis from causes unrelated to that procedure, and 18 others were lost to follow-up analysis, leaving a total of 241 (92%) available for follow-up review 10 years after treatment. At 10 years, 86% of all patients had less leg pain than preoperatively; 82% were employed at a capacity equal to or more strenuous than before injection, 9% had a less strenuous job, 1% were disabled, and 8% had retired (Tables 2 and 3 ). During these 10 years, 54 (20.8%) of these 268 patients underwent back surgery. Of this subgroup, a greater percentage were employed at heavy manual labor or driving motor vehicles (46% vs. 32%), and more were involved with workmen's compensation or litigation (30% vs. 24%). The physical findings, history, and number of levels injected in these 54 (Table  4) . Forty-two of these patients underwent a variety of nerve root explorations, four had decompressive laminectomies, and seven had spinal fusion and laminectomy. One patient had unremitting symptoms and underwent reinjection of chymopapain on the same side and at the same interspace 3 months later at another institution. That procedure failed to provide pain relief and he subsequently had two further open laminectomies for disc-related problems that failed to improve his poor outcome.
Five patients required open root explorations within 8 weeks of their injections. Two of these patients had progressive weakness and underwent surgery within 1 week of chymopapain treatment; extruded disc fragments were found and both patients ultimately did well. Two patients were explored 7 weeks after injection for stable weakness and unrelenting pain. One had an extruded disc fragment and one a protruded disc; both ultimately did well. One patient with a normal neurological examination and unrelenting back and leg pain underwent exploration but no disc or foraminal pathology was found. He continued to do poorly.
Another 17 patients came to surgery between 8 weeks and 1 year later. Included in this group was a patient who had a three-level disc injection for mild disc protrusions at L-3, L-4, and L-5, superimposed on a congenitally narrow canal. He failed to improve and developed pseudoclaudication for which he underwent a three-level decompressive laminectomy within 3 months; however, his ultimate outcome was poor.
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more than 1 year after their injections, which prompted later surgical intervention. Four of these patients underwent root explorations; disc protrusions were found in all four, and three of them did well after surgery. Three others underwent spinal fusion and laminectomy, and the remaining patient had a decompressive laminectomy. All of these four patients demonstrated spondylotic pathology, and three of them also did well. Twenty-four patients achieved relief with chymopapain and did well for more than l year, but later they experienced a separate and distinct event that led to the acute onset of back and leg pain which necessitated open back surgery. Of these 24, 20 underwent root explorations (13 had disc-related pathology and seven had foraminal or gutter stenosis). Two patients underwent fusion and laminectomy and two had decompressive laminectomies; all of these four patients had primarily spondylotic/stenotic changes. Of all these 24 patients, 14 had disc pathology, 12 of whom did well after surgery, and 10 had foraminal encroachment, seven of whom did well after surgery.
In summary, of these 54 patients undergoing further surgery, 32 were found to have discogenic pathology and 26 of these patients ultimately did well, 21 patients had primarily spondylotic pathology and 13 of these did well; the patient with truly negative exploration did poorly (Table 5) . Forty-eight of these 54 patients required only one spine procedure after chemonucleolysis. Six patients underwent a series of operations; three of these had separate and distinct procedures for recurrent disc disease and did well, while three patients with multiple surgery directed toward unremitting symptoms did poorly.
Ten years after chymopapain injection, 64.6% of the 54 patients who had subsequently undergone open back surgery had obtained relief of their presenting radicular symptoms, and 75% were employed at a level of exertion comparable to or more strenuous than their preinjection occupations (Tables 2 and 3 ). Within this total group of 54, there were 50 patients who initially underwent chemonucleolysis without prior laminectomy and then later needed an open operation for disc herniation or spondylosis. For this group the mean age at injection was 38.8 years. There were 35 males and 15 males. Their occupations were classified as sedentary in eight cases, light manual labor in 19, heavy manual labor in 19, and involved much motor-vehicle driving in four; 15 of these patients received workmen's compensation and eight were engaged in litigation. Seventeen of the 50 patients had motor weakness involving one myotomal distribution, and 10 had abnormal sensory examinations. Thirty-two patients demonstrated narrowing of an interspace on plain x-ray films, with spondylosis noted in 30 and spondylolisthesis in three cases. Of the group of 50 patients, the L-3 level was injected in one, the L-4 was injected in 13, the L-5 level was injected in 12, the L-3 plus L-4 were injected in two, the L-4 and L-5 were injected in 22, and no patient had a threelevel injection. At the 10-year analysis, 70.5% reported relief of their presenting radicular symptoms, and 77.3% were employed at a level of exertion as good as or better than that before injection (Tables 2 and 3 ). These long-term outcomes compare acceptably with those for the group as a whole. It may be stated that chymopapain chemonucleolysis does not necessarily prejudice the outcome of subsequent open procedures, should these be needed.
Twelve patients had surgery prior to chymopapain and four of these required further surgery after their injections. Although the numbers involved are too small for statistical confirmation by Fisher's exact test for 2 x 2 tables, patients with chymopapain injections after prior back surgery are less likely to require further surgical intervention if: 1) the duration of chronic symptoms prior to injection is more than 4 years; 2) the interval between the initial surgery and the chymopapain injection is longer than 35 months (p = 0.067); 3) chymopapain injections are carried out at another interspace or on the other side of the same interspace as previously treated (p > 0.10); or 4) the patients experienced relief from their symptoms after the initial surgery before requiring chymopapain injection (p = 0.067) ( Tables 2 and 3) .
Nine patients underwent repeat myelography after chemonucleolysis but were subsequently managed conservatively. Seven presented with radicular symptoms within 1 year of their injections and two patients suffered persistent pain which prompted myelographic studies at later reevaluation. In all cases, myelography showed significantly fewer defects or was normal when compared to myelography preceding chemonucleolysis. No evidence of arachnoiditis was demonstrated in these patients. Four patients received workmen's compensation or had litigation pending; none had undergone prior open surgery; four had undergone single-level chemonucleolysis, four had two-level injections, and one had three levels injected. At 10 years, only 44.4% experienced relief of their presenting radicular symptoms and 66.7 % were employed at a position equivalent to their levels of exertion before injection.
Anecdotally, one patient had chymopapain injected at L-4 and L-5 after myelography showed a midline L-4 disc herniation and abnormal discography at both spaces; he became asymptomatic postoperatively and returned to his former occupation. Nine years later, complaints of urinary hesistancy prompted a myelogram which revealed a neurofibroma of the right S-1 root; the only known tumor in this series.
Workmen's compensation or litigation was a consideration in 60 cases. Over 61% were employed at heavy manual labor or driving motor vehicles; 26.7 % required further open procedures, compared to 20.2% for the group as a whole. At 10 years, only 68.5% were employed at the same level as preoperatively, compared to 81.7% in the group as a whole (Tables 2 and 3) . The 67 patients involved in heavy manual labor showed similarities, and 45% of them had compensation or litigation pending initially. Almost 29% required further open procedures, and 73.8% remained at work in heavy manual labor 10 years later (Table 3) . By way of comparison, only 20% of the 91 patients involved in light manual labor at the time of their injection subsequently required open procedures. At the 10-year follow-up review, 78 of these 91 patients were employed at the same or more vigorous capacity as before injection.
Patient results were evaluated relative to the number of interspaces injected with chymopapain. Of the 134 patients with one disc injected, 29 required later open procedures. At 10 years, 90% of the 134 patients reported relief of their radicular leg pain and 78% were employed at the same or a more vigorous level compared with before the injection. Of the 124 patients with two discs injected, 24 required later open procedures. At 10 years, 83% of these 124 patients reported relief of their radicular leg pain and 78 % were employed at the same or a more vigorous level compared with before the injection. Of the 10 patients with three discs injected, one required a later open procedure. At l0 years, seven of these 10 patients reported relief of their radicular leg pain and six were employed at the same or a more vigorous level compared with before injection.
At the 10-year review, of all the 268 patients injected with chymopapain, 86% were judged as being successfully treated based upon relief of their presenting radicular leg pain, and 82% were judged successes regarding employment at the same or a more vigorous capacity compared with before injection. Among these patients with ultimate therapeutic success, however, are included some who required further surgery after their injections. Of the total of 54 patients who underwent open procedures after their chymopapain injections, 30 had surgery either within 1 year of the injection or to relieve unremitting symptoms (these 30 must be considered to represent failures of chemonucleolysis therapy). The remaining 24 patients underwent open procedures for separate and distinct acute events that occurred years after excellent results from their chymopapain injections.
After subtracting all 30 patients with procedures
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aimed at unremitting symptoms after failed chemonucleolysis, the overall success rates for the total group at 10 years were 80.1% based upon relief of presenting radicular leg pain and 75.1% based upon employment at the same or a more vigorous level of activity compared to before injection (Tables 2 and 3 ).
Presenting Factors Influencing Clinical Outcome
In an attempt to determine what presenting factors might be related to subsequent surgery, two-way tables with chi-square tests (categorical variables) and t-tests (continuous variables) were constructed to compare the 30 patients undergoing further open procedures to address the original radicular complaint. None of the univariate comparisons showed statistically significant differences, although there is some evidence that litigation cases more likely undergo subsequent open procedures than do nonlitigation cases (23.1% vs. 9.9%, p = 0.054) and that patients with preinjection spinal x-ray films indicating spondylolisthesis more often have further surgery than do the rest (50% (two of four) vs. 10.6%, p = 0.063). Sedentary workers undergo fewer further operations than do all the other occupational categories together (4.7% vs. 14.2%, statistically significant at p = 0.037).
Associations among pretreatment factors and longterm successes were assessed for 5-year and 10-year outcomes utilizing the chi-square test (categorical variables) and the t-test (analytical variables). In order to be declared a "therapeutic success," the patients had to have improved radicular symptoms of leg pain and, if under retirement age, to be maintaining occupational status of equal or greater physical exertion than before injection. Patients who had retired early for any reason whatsoever were considered failures, as were all of the 30 patients undergoing further open procedures directed at unremitting initial radicular symptoms, regardless of their reported ultimate symptomatic outcomes. Patients who were lost to follow-up review before the appropriate time were excluded.
When considered singly, the following variables were significantly associated with the 5-year outcome: occupation (p = 0.010), with higher success among sedentary workers and lower among heavy manual labors; workmen's compensation (p = 0.001); litigation (p < 0.001); and a history indicating a work-related injury (p = 0.005) and spondylotisthesis (p = 0.025). The following variables were found to have statistically significant association with the 10-year outcome: litigation (p < 0.001); workmen's compensation (p = 0.004); previous surgery (p = 0.049), with lower success rates for chemonucleolysis among those with prior open procedures upon their lumbar spines; a history indicating a workrelated injury (p = 0.007); and preinjection spine x-ray films demonstrating spondylolisthesis (p = 0.028).
The combined effects of the factors deemed significant by univariate analysis in the 5-and 10-year out-comes were further analyzed using a stepwise MantelHaentzel variable selection approach with dichotomous variables and then analyzed by a multivariate logistic regression approach. Multivariate analysis confirmed the findings of the prior univariate analysis. Exclusion from consideration of the occupational status, history of work-related injury, and compensation/litigation status at chemonucleolysis did not uncover additional presenting medical factors that might influence ultimate outcome.
Discussion
There exists a need for the critical appraisal of longterm clinical outcome of large numbers of patients for the evaluation of chymopapain chemonucleolysis as a surgical alternative to open procedures, including laminectomy and discectomy, in the therapeutic approach to radicular symptomatology due to myelographically confirmed intervertebral disc herniation. 3-5' 7"~~ Retrograde spondylolisthesis was found to correlate with a higher incidence of therapeutic failure and subsequent open laminectomy. Significantly, retrolisthesis and scoliosis contralateral to the side of the disc prolapse have previously been correlated by Houser, et al., 3 with persistence of symptoms after chemonucleolysis. Retrograde spondylolisthesis may be considered to be a radiographic predictor of unfavorable outcome after chemonucleolysis.
Myelography is considered an essential step in preoperative evaluation and is used in every case to confirm the diagnosis of disc protrusion or extrusion, exclude other causes of back and leg pain such as intraspinal tumor, and establish the position of the thecal sac. The avoidance of unexpected arachnoidal diverticuli and conjoined nerve roots facilitates avoiding penetration of the subarachnoid space.
Myelography is performed at least 24 hours prior to chemonucleolysis to minimize any synergistic adverse effects which may in combination be responsible for the rare cauda equina or spinal cord lesions attributable to chemonucleolysis by inadvertent penetration of the cerebrospinal fluid (CSF) space during the procedure. The CSF space has never been entered during the performance of chemonucleolysis at the Mayo Clinic due to strict adherence to needle introduction by the lateral approach with a stop-and-go technique with constant C-arm imaging of anteroposterior and lateral projections with each change in needle insertion or trajectory. Intrathecal penetration of discographic dye constituted an indication for aborting the chemonucleolysis. Similarly, transdural needle placement is contraindicated.
A high incidence of multiple disc injections based on discographic guidance for chemonucleolysis was not associated with any increased incidence of early or late failures or subsequent open explorations. A history or myelographic picture suggestive of extruded rather than protruded disc did not influence therapeutic outcome, nor did the presence of mild motor deficit in the affected myotome.
Patients with chymopapain injections after prior back surgery were less likely to require further surgical intervention if the chronic symptoms prior to their injection lasted more than 4 years; if the interval between the initial surgery and the chymopapain injection was longer than 35 months; if chymopapain injections were carried out at another interspace or on the other side of the same interspace as previously treated; and if the patients experienced relief from their symptoms after the initial surgery before requiring chymopapain injection.
One hundred and six patients (40%) had postoperative paraspinal muscle spasms of several days' duration, which did not correlate with clinical outcome. Postoperative back spasm is treated by whirlpool therapy, short-term narcotic and muscle relaxant administration and, if so indicated, by bracing with a long lumbosacral garment for the first 6 to 8 weeks postoperatively.
There were no instances of allergic reactions, anaphylaxis, subarachnoid hemorrhage, myelopathy, or disc space infections in this series. The acknowledged and reported side effects of the intradiscal use of chymopapain are well stated in the manufacturer's packaging inserts and were factors recognized at the time of this initial study; they have been more widely recognized since widespread clinical usage of this technique was resumed in 1983. Adverse reactions have included anaphylaxis in a total of 0.5% of cases, with eight reported related deaths. Paraparesis and paraplegia have been reported as occurring in one out of 2000 cases. Acute transverse myelitis has been reported in one of 18,000 cases, occurring 2 to 3 weeks following injection. This may be an unavoidable phenomenon and a risk inherent in the procedure. Discitis, both bacterial and aseptic, has been reported. Strict aseptic operating room technique is used to minimize interspace infection.
To address these problems, since 1983 we have routinely used general endotracheal anesthesia to ascertain optimum patient positioning during the operation and to secure control of the airway. Cimetidine (300 mg) and Benadryl (diphenydramine, 50 mg) every 8 hours for 36 hours prior to injection of chymopapain have been used to minimize the occurrence and severity of any anaphylactic reaction. At present, each patient has a chymorast test preoperatively to screen for antibodies and to minimize the occurrence of anaphylaxis. There are recognized false-positive and false-negative results with this test.
In a similar patient population to that in this study, Uihlein, et al., j4 cited a 15% failure rate after laminectomy with and without fusion in over 900 patients, with 6% requiring reoperation; theirs was an 8-year follow-up period.
The present criteria for patient selection are the same as for this retrospective study. We include the very rare patient who has had a recurrent disc protrusion at the same space with a good result following surgical extirpation of the disc at least 3 years previously. Large midline disc protusions threatening canal occlusion in the congenitally narrow lumbar canal or in the normal patient are never treated with chemonucleolysis. This policy has been adopted to prevent infolding of the posterior longitudinal ligament along with persistence of a large extradural defect which in combination would be a cause of postinjection cauda equina syndrome.
The long-term outcomes for patients undergoing subsequent procedures compare acceptably with those of the group as a whole. It may be stated that chemonucleolysis does not necessarily prejudice the outcome of subsequent open procedures, should these be needed. A higher rate of therapeutic failure and subsequent surgical intervention was seen in patients with injections soon after an unsuccessful open procedure on the same side at the same interspace; with compensation or litigation pending; with a history of a work-related injury; with employment involving heavy manual labor or extensive driving; and with preinjection plain spine x-ray films indicating retrograde spondylolisthesis.
Chemonucleolysis with chymopapain is demonstrated to be a safe and effective treatment of radicular complaints referrable to documented intervertebral disc disease. The long-term results compare favorably to those of similarly selected patients undergoing open surgical procedures.
